Submissions from 2023
Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6, SC Bain, Katherine Tuttle, and See Full List of Authors in Comments
Proteomic changes induced by longevity-promoting interventions in mice., Adam R Burns, Jack Wiedrick, Alicia Feryn, Michal Maes, Mukul K Midha, David H Baxter, Seamus R Morrone, Timothy J Prokop, Charu Kapil, Michael R Hoopmann, Ulrike Kusebauch, Eric W Deutsch, Noa Rappaport, Kengo Watanabe, Robert L Moritz, Richard A Miller, Jodi A Lapidus, and Eric S Orwoll
Identifying Systemic errors in refilling insulin to prevent another hospitalization: An RCA, John Butler, Mikayla Button, Jared Fincher, Rakin Solaiman, and Michael Woodfin
American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence., James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Aneesa Chowdhury, Nayantara Coelho-Prabhu, Rishi Das, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Jonathan Sadik, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, Selena Zhou, and Bashar J Qumseya
American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations., James L Buxbaum, Martin Freeman, Stuart K Amateau, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Sherif E Elhanafi, Nauzer Forbes, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly H Ruan, Sunil G Sheth, Nikhil R Thiruvengadam, Nirav C Thosani, and Bashar J Qumseya
A quality improvement initiative to bridge gaps in treatment and interprofessional care of chronic kidney disease, DA Cappel, Katherine Tuttle, and See all authors in comments
Home Dialysis Curriculum Implementation for Health Care Workers Using Project ECHO Principles: A Feasibility Report From NKF-KDOQI., Christopher T Chan, Barbara Dommert-Breckler, Jordan Cannon, Renin Cassidy, Karen Crampton, Danilo Concepcion, Stephanie Hutchinson, Jessica Joseph, Rajnish Mehrotra, Gary Moore, Nancy Pierce, Matthew B Rivara, and Katy Wilkens
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network., Dhruti P Chen, Margaret E Helmuth, Abigail R Smith, Pietro A Canetta, Isabelle Ayoub, Krzysztof Mucha, Mahmoud Kallash, Jeffrey B Kopp, Rasheed Gbadegesin, Brenda W Gillespie, Larry A Greenbaum, Rulan S Parekh, Tracy E Hunley, C John Sperati, David T Selewski, Jason Kidd, Aftab Chishti, Kimberly Reidy, Amy K Mottl, Debbie S Gipson, Tarak Srivastava, Katherine E Twombley, CureGN Consortium, and Katherine Tuttle
Does Offloading with Felt Foot Plates Heal Diabetic Foot Ulcers?, Deborah Christensen and Albert Botchway
Empagliflozin in Patients with Chronic Kidney Disease., The EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, Radica Alicic, Ann Cooper, and Lisa Davis
Tirzepatide decreases systolic and diastolic blood pressure., Sidar Copur, Atalay Demiray, David Cherney, Katherine Tuttle, and Mehmet Kanbay
Tirzepatide and potential use for metabolically healthy obesity., Sidar Copur, Cem Tanriover, Furkan Yavuz, Katherine R Tuttle, and Mehmet Kanbay
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?, Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine R Tuttle, and Mehmet Kanbay
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial., Michael I D'Angelica, Ryan J Ellis, Jason B Liu, Brian C Brajcich, Mithat Gönen, Vanessa M Thompson, Mark E Cohen, Susan K Seo, Emily C Zabor, Michele L Babicky, David J Bentrem, Stephen W Behrman, Kimberly A Bertens, Scott A Celinski, Carlos H F Chan, Mary Dillhoff, Matthew E B Dixon, Carlos Fernandez-Del Castillo, Sepideh Gholami, Michael G House, Paul J Karanicolas, Harish Lavu, Shishir K Maithel, John C McAuliffe, Mark J Ott, Bradley N Reames, Dominic E Sanford, Umut Sarpel, Courtney L Scaife, Pablo E Serrano, Travis Smith, Rebecca A Snyder, Mark S Talamonti, Sharon M Weber, Adam C Yopp, Henry A Pitt, and Clifford Y Ko
Needs Assessment: Characterizing resident knowledge gaps in inpatient care of persons with Cystic Fibrosis to inform a quality improvement educational intervention, S Eglin, M Drobny, and AA Lambert
Empagliflozin in Patients with Chronic Kidney Disease., EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, and The EMPA-KIDNEY Collaborative Group
Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study, JRS Fernandez, Katherine Tuttle, and See full list of authors in comments
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017., Rodolfo J Galindo, Shealeigh A Inselman, Guillermo E Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed K Ali, Katherine R Tuttle, and Rozalina G McCoy
960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez
961-P: Comparison of Glucose Metrics by Capillary Blood Glucose and Continuous Glucose Monitoring among People with Type 2 Diabetes on Hemodialysis, Rodolfo J. Galindo, Bobak Mozzami, Amany Y.G. Gerges, Limin Peng, Katherine R. Tuttle, and Guillermo Umpierrez
960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Katherine Tuttle, and See full list of authors in comments
Long COVID and the Heart, Tyler Gluckman
Temporal Shifts In Guideline-directed Medical Therapy Prescribed At Discharge To Heart Failure Patients In A Large US Integrated Health System, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy., Thorvardur R Halfdanarson, Nadine Mallak, Scott Paulson, Chandrikha Chandrasekharan, Mona Natwa, Ayse Tuba Kendi, and Hagen F Kennecke
Biliary and pancreatic stents., Samuel Han; Jorge V Obando; Amit Bhatt; Juan Carlos Bucobo; Dennis Chen; Andrew P Copland; Koushik K Das; Mohit Girotra; Allon Kahn; Kumar Krishnan; Sonali S Sakaria; Monica Saumoy; Guru Trikudanathan; Arvind J Trindade; Julie Yang; Ryan J Law; ASGE Technology Committee Chair; David R Lichtenstein; and (previous Committee Chair, 2019-2021)
People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action., Hiddo Jl Heerspink, David Zi Cherney, Per-Henrik Groop, Chantal Matthieu, Peter Rossing, Katherine R Tuttle, and Janet B McGill
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis., Hiddo J L Heerspink, Naveed Sattar, Imre Pavo, Axel Haupt, Kevin L Duffin, Zhengyu Yang, Russell J Wiese, Jonathan M Wilson, Andrea Hemmingway, David Z I Cherney, and Katherine Tuttle
Tirzepatide reduces albuminuria in patients with type 2 diabetes: post-hoc pooled analysis of SURPASS 1-5, Hiddo J. Heerspink, Katherine Tuttle, and See full list of authors in comments
Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease, HJL Heerspink, Katherine Tuttle, and See all authors in comments
Factors impacting adherence to antidiabetic medications and health outcomes in diabetes mellitus patients in Medicare populations, Kelli Hoang, Kelly Simpson, and Danny Wallenslager
The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis., Mehmet Kanbay, Sidar Copur, Dimitrie Siriopol, Abdullah B Yildiz, Metehan Berkkan, Kathherine R Tuttle, and Carmine Zoccali
Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention., Judit Karacsonyi, Karen Deffenbacher, Keith H Benzuly, James D Flaherty, Khaldoon Alaswad, Mir Basir, Michael S Megaly, Farouc Jaffer, Darshan Doshi, Paul Poommipanit, Jaikirshan Khatri, Mitul Patel, Robert Riley, Abdul Sheikh, Jason R Wollmuth, Ethan C Korngold, Barry F Uretsky, Robert W Yeh, Raj H Chandwaney, Ahmed M Elguindy, Khalid Tammam, Nidal AbiRafeh, Christian W Schmidt, Brynn Okeson, Spyridon Kostantinis, Bahadir Simsek, Bavana V Rangan, Emmanouil S Brilakis, and Daniel R Schimmel
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association., Sadiya S Khan, Josef Coresh, Michael J Pencina, Chiadi E Ndumele, Janani Rangaswami, Sheryl L Chow, Latha P Palaniappan, Laurence S Sperling, Salim S Virani, Jennifer E Ho, Ian J Neeland, Katherine Tuttle, Radhika Rajgopal Singh, Mitchell S V Elkind, Donald M Lloyd-Jones, and American Heart Association
Real-World Outcomes of Impella 5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry, A Kilic, Jacob Abraham, and See full list of authors in comments
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease., Jill R Krissberg, Michelle M O'Shaughnessy, Abigail R Smith, Margaret E Helmuth, Salem Almaani, Diego H Aviles, Kaye E Brathwaite, Yi Cai, Daniel Cattran, Rasheed Gbadegesin, Dorey A Glenn, Larry A Greenbaum, Sandra Iragorri, Koyal Jain, Myda Khalid, Jason Kidd, Jeffrey Kopp, Richard Lafayette, Jerome C Lane, Francesca Lugani, Jordan G Nestor, Rulan S Parekh, Kimberly Reidy, David T Selewski, Christine B Sethna, C John Sperati, Katherine Tuttle, Katherine Twombley, Tetyana L Vasylyeva, Donald J Weaver, Scott E Wenderfer, Keisha Gibson, and CureGN Consortium
Assessment of medication adherence among adults with glomerular disease, JR Krissberg, Katherine Tuttle, and See all authors in comments
“Research Coordinator Mentoring Program – Participant Presentations”, Kelli Kuykendall
Evaluation of solid-phase panreactivity with negative direct antiglobulin testing., J T Little and D P Blackall
Equity and Quality of Global CKD Care - what are we waiting for?, Valerie A Luyckx, Ayah Elmaghrabi, Manisha Sahay, Nicole Scholes-Robertson, Laura Sola, Tobias Speare, Elliot K Tannor, Katherine Tuttle, and Ikechi G Okpechi
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis., Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder, Viji Nair, Felix Eichinger, Sebastian Martini, Adebowale D Ademola, Vincent Boima, Heather N Reich, Jamal El Saghir, Bradley Godfrey, Wenjun Ju, Emily C Tanner, Virginia Vega-Warner, Noel L Wys, Sharon G Adler, Gerald B Appel, Ambarish Athavale, Meredith A Atkinson, Serena M Bagnasco, Laura Barisoni, Elizabeth Brown, Daniel C Cattran, Gaia M Coppock, Katherine M Dell, Vimal K Derebail, Fernando C Fervenza, Alessia Fornoni, Crystal A Gadegbeku, Keisha L Gibson, Laurence A Greenbaum, Sangeeta R Hingorani, Michelle A Hladunewich, Jeffrey B Hodgin, Marie C Hogan, Lawrence B Holzman, J Ashley Jefferson, Frederick J Kaskel, Jeffrey B Kopp, Richard A Lafayette, Kevin V Lemley, John C Lieske, Jen-Jar Lin, Rajarasee Menon, Kevin E Meyers, Patrick H Nachman, Cynthia C Nast, Michelle M O'Shaughnessy, Edgar A Otto, Kimberly J Reidy, Kamalanathan K Sambandam, John R Sedor, Christine B Sethna, Pamela Singer, Tarak Srivastava, Cheryl L Tran, Katherine Tuttle, Suzanne M Vento, Chia-Shi Wang, Akinlolu O Ojo, Dwomoa Adu, Debbie S Gipson, Howard Trachtman, and Matthias Kretzler
Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study, LH Mariani, Katherine Tuttle, and See all authors in comments
Comparison of in-clinic only to in-clinic plus virtual mental health screens of adults with cystic fibrosis during SARS-CoV-2 pandemic, KG Mertz, M Ingoldby, T Vance, and AA Lambert
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine Tuttle
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection., Erin D Michos, George L Bakris, Helena W Rodbard, and Katherine R Tuttle
Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, JE Milton, A Chavez, K Kuykendall, and AA Lambert
Quality Improvement: Increasing staff and patient awareness of and knowledge of genetic therapy research, Joan Milton
“Cardiac Amyloid Pearls & Pitfalls”, Deirdre Mooney
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update., Sankar D Navaneethan, Sophia Zoungas, M Luiza Caramori, Juliana C N Chan, Hiddo J L Heerspink, Clint Hurst, Adrian Liew, Erin D Michos, Wasiu A Olowu, Tami Sadusky, Nikhil Tandon, Katherine R Tuttle, Christoph Wanner, Katy G Wilkens, Jonathan C Craig, David J Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H de Boer, and Kamlesh Khunti
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A Scientific Statement from the American Heart Association., C Ndumele, Katherine Tuttle, and See all authors in comments
First-line therapy in T2D: Has Metformin been “dethroned, Joshua J Neumiller and Radica Alicic
Incorporating Evidence and Guidelines for Personalized Care of Diabetes and Chronic Kidney Disease., Joshua J Neumiller, Radica Alicic, and Katherine Tuttle
Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States., Susanne B Nicholas, Radica Z Alicic, and Jenny Shen
Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020., Susanne B Nicholas, Kenn Daratha, Radica Alicic, Cami R Jones, Lindsey M Kornowske, Joshua J Neumiller, Samuel T Fatoba, Sheldon X Kong, Rakesh Singh, Keith C Norris, and Katherine Tuttle
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial., Erika A Petersen, Thomas G Stauss, James A Scowcroft, Michael J Jaasma, Elizabeth S Brooks, Deborah R Edgar, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, and Nagy A Mekhail
Noninvasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cutoff values., Pankaj Rajvanshi and Srikrishna Gurumurthy
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis., Michelle N Rheault, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Pietro Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J L Heerspink, Jula K Inrig, Gianna M Kirsztajn, Donald Kohan, Radko Komers, Laura A Kooienga, Kenneth Lieberman, Alex Mercer, Irene L Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman, DUPRO Steering Committee and DUPLEX Investigators, and Katherine Tuttle
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease., Peter Rossing, Florian M M Baeres, George Bakris, Heidrun Bosch-Traberg, Mette Gislum, Stephen C L Gough, Thomas Idorn, Jack Lawson, Kenneth W Mahaffey, Johannes F E Mann, Henriette Mersebach, Vlado Perkovic, Katherine Tuttle, and Richard Pratley
1460-P: Prevalence of Chronic Kidney Disease Associated with Type 1 Diabetes in the U.S., Peter Rossing, Per-Henrik Groop, Rakesh Singh, Robert Lawatscheck, and Katherine Tuttle
Phase II doseselection, randomized double-blind trial of the ASI, BI 690517, alone and in combination with EMPA in people with CKD, P Rossing, Katherine Tuttle, and Full List of Authors in Comments
Prevalence of chronic kidney disease associated with type 1 diabetes in the US, P Rossing, Katherine Tuttle, and See full list of authors in comments
Evaluation of an Integrated Intervention to Address Clinical Care and Social Needs Among Patients with Type 2 Diabetes., Sarah E Roth, Benjamin Gronowski, Kyle Jones, Rachel A Smith, Sonya Kauffman Smith, Keri B Vartanian, and Bill J. Wright
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial., William E Russell, Brian N Bundy, Mark S Anderson, Laura A Cooney, Stephen E Gitelman, Robin S Goland, Peter A Gottlieb, Carla J Greenbaum, Michael J Haller, Jeffrey P Krischer, Ingrid M Libman, Peter S Linsley, S Alice Long, Sandra M Lord, Daniel J Moore, Wayne V Moore, Antoinette M Moran, Andrew B Muir, Philip Raskin, Jay S Skyler, John M Wentworth, Diane K Wherrett, Darrell M Wilson, Anette-Gabriele Ziegler, and Kevan C Herold
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis., Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R Tuttle, Luis M Ruilope, Peter Rossing, Robert Toto, Stefan D Anker, Zhi-Hong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George Bakris, and FIDELIO-DKD and FIGARO-DKD Investigators
Clinical Practice Panel: Diabetes Mellitus Management in a Medical-Surgical Unit, Jane Tajonera
Analysis of eGFR vs CrCl to monitor for renal dose adjustments within Central Refill, Briana Thompson and Angela Koerner
Targeting of insulin receptor endocytosis as a treatment to insulin resistance., Bryce Tim, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
2023 Cardiometabolic Health Congress (CMHC) Women’s Health and Wellness Masterclass, Katherine Tuttle
“90% of people with chronic kidney disease don’t know they have it. Do you know the risk factors?”, Katherine Tuttle
CKD in Diabetes and the Journey to Kidney Health, Katherine Tuttle
Clinicopathologic Conference “ Nephrotic Syndrome”, Katherine Tuttle
Destination Kidney Health for Diabetes and CKD, Katherine Tuttle
Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle
Effects of Long COVID, Katherine Tuttle
“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”, Katherine Tuttle
“FDA approves new indication for Jardiance”, Katherine Tuttle
“GLP1 RAs and Kidney Outcomes in Diabetes”, Katherine Tuttle
Harvard Medical School – Diabetes Comorbidities and Complications, Katherine Tuttle
“Jardiance approved for adults with Chronic Kidney Disease”, Katherine Tuttle
KDIGO Conference on CKD, Rome Italy, Katherine Tuttle
Kidney Health in View for Diabetes and CKD, Katherine Tuttle
Late breaking clinical trials: “Asi in CKD”, Katherine Tuttle
Most Powerful Tools Ever to Slow the Progression of Diabetic Kidney Disease: How and When to Use them Optimally”, Katherine Tuttle
Multidisciplinary Strategies for Implementation, Katherine Tuttle
“On par with the biggest breakthroughs in medicine”, Katherine Tuttle
“Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study”, Katherine Tuttle
“Preserving Kidney Health in Diabetes”, Katherine Tuttle
Protective effects of GLP-1 Receptor Agonists, Katherine Tuttle
“Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”, Katherine Tuttle
"Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes", Katherine Tuttle
Research presented at the American Society of Nephrology meeting, Katherine Tuttle
“Scientists find promising new drug for chronic kidney disease”, Katherine Tuttle
“Spokane doctor’s breakthrough kidney disease treatment shows promising results”, Katherine Tuttle
“The Journey to Kidney Health is the Reward for People with Diabetes and CKD”, Katherine Tuttle
“Therapeutic Transformation of Kidney Care by Groundbreaking Clinical Trials”, Katherine Tuttle
A Quality Improvement Initiative to Bridge Gaps in Treatment and Interprofessional Care of CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Research Diversity (AIM-AHEAD), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Assessment of Medication Adherence Among Adults with Glomerular Disease, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
